PharmaShots | Incisive News in 3 Shots

Subscribe Now

HER2 Mutant

Daiichi Sankyo’s Enhertu Receives the MHLW’s Approval as First HER2 Directed Therapy for HER2 Mutant Metastatic Non-Small Cell Lung Cancer

Daiichi Sankyo’s Enhertu Receives the MHLW’s Approval as First HER2 Directed Therapy for HER2 Mutant Metastatic Non-Small Cell Lun...

August 23, 2023

Daiichi Sankyo and AstraZeneca Report the US FDA Acceptance for Priority Review of Enhertu to Treat HER2 Mutant Metastatic Non-Small Cell Lung Cancer

Daiichi Sankyo and AstraZeneca Report the US FDA Acceptance for Priority Review of Enhertu to Treat HER2 Mutant Metastatic Non-Sma...

April 19, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us